MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company, announced that the Company’s Chairman, CEO and Co-Founder, Shankar Musunuri, PhD, MBA, and Chief Scientific Officer, Head of Research, Development and Medical, Arun Upadhyay, PhD, will present at the American Association of Physicians of Indian Origin (AAPI) Convention and Scientific Assembly, July 6 – 9, 2023 in Philadelphia, PA.
“The AAPI is an impressive organization that fosters the continued leadership of healthcare professionals of Indian origin through educational and networking opportunities, while also supporting the next generation of leaders and giving back to people in need through its charitable foundation,” said Dr. Musunuri. “We look forward to interacting with top physicians, health professionals, academicians, and scientists from across the country to drive positive change throughout our dynamic healthcare environment.”
“It’s an honor to share more about Ocugen’s scientific platforms, especially modifier gene therapy, with this important audience,” said Dr. Upadhyay. “Opportunities like this for an open dialogue among industry and practitioners is critical to advancing treatment options and providing access for patients.”
Details on Dr. Upadhyay’s participation are as follows:
Product Theater: “Emerging Cell and Gene Therapy Technologies: Novel curative approaches to breaking barriers in disease management”
Date: Friday, July 7, 2023
Time: 8:50 – 9:10 a.m. ET
Location: Philadelphia Marriott Downtown, Philadelphia, PA – 5th Floor – Salon BCD
Details on Dr. Musunuri’s participation are as follows:
CEO Leaders Forum: “Shaping Healthcare for the Future”
Date: Saturday, July 8, 2023
Time: 3 – 4:15 p.m. ET
Location: Philadelphia Marriott Downtown, Philadelphia, PA – Rooms 302-306
For more information, visit www.ocugen.com.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News.